Kieran Crowley has nearly 20 years’ experience leading formulation and product development teams in the pharmaceutical industry, including selecting and optimizing drug delivery systems based on the physicochemical and biopharmaceutics properties of drug candidates. With expertise in oral delivery of poorly soluble compounds, Dr. Crowley has successfully advanced products using
a variety of methods including hot melt extrusion, nanomilling, and lyophilization. At Quotient Sciences, Dr. Crowley oversees the design and implementation of adaptive clinical programs and integrated product manufacturing, driving real-time decision making in early development. Dr. Crowley received his Ph.D. in pharmaceutics from the University of Bradford, U.K., and was a post-doctoral researcher at the University of Wisconsin-Madison.
Read More